| 000 | 03227naa a22005057i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-MLS-036 | ||
| 003 | local | ||
| 005 | 20261005174904.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2024 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.1186/s13073-024-01315-6 _2doi |
|
| 035 | _a(local)EuropePMC:PMC10976780 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aMichaela Unger _eauthor. |
|
| 245 | 1 | 0 |
_aDeep learning in cancer genomics and histopathology. / _cMichaela Unger; Jakob Nikolas Kather. |
| 264 | 1 |
_a[Place of publication not identified] : _bBMC, _c2024. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aHistopathology and genomic profiling are cornerstones of precision oncology and are routinely obtained for patients with cancer. Traditionally, histopathology slides are manually reviewed by highly trained pathologists. Genomic data, on the other hand, is evaluated by engineered computational pipelines. In both applications, the advent of modern artificial intelligence methods, specifically machine learning (ML) and deep learning (DL), have opened up a fundamentally new way of extracting actionable insights from raw data, which could augment and potentially replace some aspects of traditional evaluation workflows. In this review, we summarize current and emerging applications of DL in histopathology and genomics, including basic diagnostic as well as advanced prognostic tasks. Based on a growing body of evidence, we suggest that DL could be the groundwork for a new kind of workflow in oncology and cancer research. However, we also point out that DL models can have biases and other flaws that users in healthcare and research need to know about, and we propose ways to address them. | |
| 540 |
_aCreative Commons Attribution. See the linked licence for the applicable terms. _uhttps://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Medical Laboratory Science. | ||
| 650 | 4 | _aGenomics | |
| 650 | 4 | _aHistopathology | |
| 650 | 4 | _aMultimodality | |
| 650 | 4 | _aDeep Learning | |
| 650 | 4 | _aPrecision Oncology | |
| 653 | _aB. Sc. Medical Laboratory Science | ||
| 653 | _aUMUN open access collection | ||
| 653 | _ahistopathology | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aJakob Nikolas Kather _eauthor. |
|
| 773 | 0 |
_tGenome medicine _gVol. 16, no. 1, (2024), pages/article 44 _x1756-994X |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC10976780 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC10976780 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1178 _d1178 |
||